MedTrace Logo

Clinical Trials

NCT02893917 | ACTIVE_NOT_RECRUITING | PHASE2
90 participants

Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2017-08-11
Completion:
2023-03-14
Conditions
  • Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation
  • Castration-Resistant Prostate Carcinoma
  • Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation
  • Metastatic Prostate Carcinoma
  • Prostate Adenocarcinoma With Neuroendocrine Differentiation
  • Stage IV Prostate Adenocarcinoma AJCC v7
Interventions
  • DRUG
Results Available
NCT02883062 | ACTIVE_NOT_RECRUITING | PHASE2
67 participants

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2017-08-02
Completion:
2019-12-18
Conditions
  • Invasive Breast Carcinoma
  • Stage II Breast Cancer AJCC v6 and v7
  • Stage III Breast Cancer AJCC v7
  • Triple-Negative Breast Carcinoma
Interventions
  • DRUG
  • PROCEDURE
Results Available
NCT02506153 | ACTIVE_NOT_RECRUITING | PHASE3
1301 participants

Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2015-11-10
Completion:
2023-09-15
Conditions
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Metastatic Cutaneous Melanoma
  • Metastatic Mucosal Melanoma
  • Metastatic Non-Cutaneous Melanoma
  • Non-Cutaneous Melanoma
  • Recurrent Cutaneous Melanoma
  • Recurrent Mucosal Melanoma
  • Recurrent Non-Cutaneous Melanoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
Results Available
NCT02345265 | ACTIVE_NOT_RECRUITING | PHASE2
70 participants

Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2016-05-23
Completion:
2022-07-07
Conditions
  • Fallopian Tube Carcinoma
  • Fallopian Tube Endometrioid Adenocarcinoma
  • Fallopian Tube Serous Adenocarcinoma
  • Ovarian Carcinoma
  • Ovarian High Grade Endometrioid Adenocarcinoma
  • Ovarian High Grade Serous Adenocarcinoma
  • Primary Peritoneal Carcinoma
  • Primary Peritoneal Endometrioid Adenocarcinoma
  • Primary Peritoneal Serous Adenocarcinoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
Results Available
NCT02143414 | ACTIVE_NOT_RECRUITING | PHASE2
53 participants

Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2015-06-30
Completion:
2022-06-01
Conditions
  • Acute Lymphoblastic Leukemia
  • B Acute Lymphoblastic Leukemia
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Recurrent Acute Lymphoblastic Leukemia
  • Refractory Acute Lymphoblastic Leukemia
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
Results Available
NCT01536522 | ENROLLING_BY_INVITATION | EARLY_PHASE1
60 participants

Asthma Inflammation Research

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2011-01-31
Completion:
2027-06-30
Conditions
  • Asthma
  • Allergic Asthma
  • Non-allergic Asthma
Interventions
  • DIETARY_SUPPLEMENT
  • BIOLOGICAL
No Results Yet
NCT01190930 | COMPLETED | PHASE3
9350 participants

Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2010-08-11
Completion:
2019-03-31
Conditions
  • Acute Lymphoblastic Leukemia
  • Adult B Lymphoblastic Lymphoma
  • Ann Arbor Stage I B Lymphoblastic Lymphoma
  • Ann Arbor Stage II B Lymphoblastic Lymphoma
  • Childhood B Acute Lymphoblastic Leukemia
  • Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Childhood B Lymphoblastic Lymphoma
  • Down Syndrome
  • Hypodiploid B Acute Lymphoblastic Leukemia
  • Philadelphia Chromosome Positive
Interventions
  • DRUG
  • OTHER
Results Available
NCT01116648 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
155 participants

Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2010-04-14
Completion:
2018-10-31
Conditions
  • Fallopian Tube Carcinoma
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian High Grade Serous Adenocarcinoma
  • Ovarian Serous Adenocarcinoma
  • Ovarian Serous Surface Papillary Adenocarcinoma
  • Primary Peritoneal Serous Adenocarcinoma
  • Triple-Negative Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
Results Available
NCT00926432 | COMPLETED | NA
26 participants

Postural Balance of the Adult

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2009-07-31
Completion:
2010-12-31
Conditions
  • Postural Balance
Interventions
  • DEVICE
No Results Yet
NCT07610317 | COMPLETED | PHASE2
72 participants

PAIN AND ANXIETY IN THE OSSEODENSIFICATION

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2023-04-15
Completion:
2024-04-30
Conditions
  • Osseodensification Drilling Technique
  • Dental Implants
Interventions
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page